The world’s most comfortable nasal swab for COVID-19 and upper respiratory pathogens including influenza and RSV.
Rhinomed is a wearable nasal technology company that seeks to radically improve the way you breathe, sleep, maintain your health, diagnose disease and take medication.
We create medical devices that are used by millions of people globally.
With a pipeline of compelling innovation focused on clear unmet clinical needs, we invite you to experience firsthand the difference Rhinomed can make to your way of life.
- Rhinomed Developing New Nasal SwabRhinomed Limited (ASX:RNO OTCQB:RHNMF), a leader in nasal airway and respiratory technology, is advanced in developing a new high-yielding nasal swab that can collect samples from the nose to test … Read more
- Rhinomed Records Positive Year On Year ResultRhinomed Limited (ASX:RNO, OTCQB: RHNMF), a leader in nasal and respiratory technology and the maker of Mute™ and Pronto™, can report its FY 20 Q4 results and preliminary unaudited full … Read more
- Rhinomed Delivers Major Milestone: Pronto to Appear in 6,336 New Stores in USRhinomed Limited (ASX:RNO, OTCQB: RHNMF), a leader in nasal and respiratory technology and the maker of Mute™ and Pronto™, today announces it has received purchase orders confirming a major distribution … Read more
- RNO Signs 12 Year Licensing Agreement With USA’s Largest Medical Cannabis OperatorRhinomed (ASX:RNO) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider … Read more
- Appendix 4E Preliminary Final ReportRhinomed (ASX:RNO) a leader in nasal respiratory technology, today released the Appendix 4E Preliminary Final Report Read a full copy of the report here.
- Business Update – June Quarter Cash Flow ReportRhinomed (ASX:RNO) a leader in nasal respiratory technology, today announced a pivotal year of growth and milestone achievement. The company can report record recognised revenues for FY18 Q4 of $874k … Read more